Atai stocks.

Get ATAI Life Sciences NV (ATAI.O) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investments

Atai stocks. Things To Know About Atai stocks.

A high-level overview of Atai Life Sciences N.V. (ATAI) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. Atai Life Sciences Announces Results from the Phase 1 Iv-To-Subcutaneous Bridging Study of Pcn-101 (R-Ketamine) Aug. 08: CI Atai Life Sciences N.V., Atai Life Sciences AG Enters into the Second Amendment to Loan and Security Agreement with the Several Banks May. 31: CIInvesting in the stock market takes a lot of courage, a lot of research, and a lot of wisdom. One of the most important steps is understanding how a stock has performed in the past. Of course, the past is not a guarantee of future performan...Atai Life Sciences (NASDAQ:ATAI) said its majority-owned unit Perception Neuroscience's therapy PCN-101 (R-ketamine) did not meet the main goal of a phase 2a trial for treatment-resistant depression.Find real-time SMCI - Super Micro Computer Inc stock quotes, company profile, news and forecasts from CNN Business.Web

Atai Life Sciences The Trade : Atai Life Sciences N.V. ATAI Florian Brand acquired a total of 20,000 shares at an average price of $1.16. The insider spent around $23,120 to buy those shares.Web

Sep 1, 2023 · Atai Life Sciences has a strong financial position with $227.5 million in cash and funding to support its operations into the 1st half of 2026. The global schizophrenia drug market is expected to ... Dec 1, 2023 · View atai Life Sciences NV ATAI investment & stock information. Get the latest atai Life Sciences NV ATAI detailed stock quotes, stock data, Real-Time ECN, charts, stats and more.

The ATAI stock price is closed at $ 1.120000 with a total market cap valuation of $ 185.93M (166.01M shares outstanding). The ATAI is trading on NASDAQ with the ...Research Atai Life Sciences' (Nasdaq:ATAI) stock price, latest news & stock analysis. Find everything from its Valuation, Future Growth, Past Performance ...Consolidated Financial Results. Cash, Cash Equivalents, and Short-term investments: Cash, cash equivalents and short-term investments totaled $209.0 million as of September 30, 2023, compared to ...Nov 3, 2023 · ATAI Life Sciences NV (ATAI) stock is trading at $1.33 as of 10:11 AM on Friday, Nov 3, an increase of $0.09, or 7.31% from the previous closing price of $1.24. The stock has traded between $1.20 and $1.34 so far today. Volume today is low. So far 138,480 shares have traded compared to average volume of 503,480 shares. Stock analysis for ATAI Life Sciences NV (ATAI:NASDAQ GM) including stock price, stock chart, company news, key statistics, fundamentals and company profile.

The Atai Life Sciences N.V. stock forecast for tomorrow is $ 1.055893, which would represent a -2.23% loss compared to the current price. In the next week, the price of ATAI is expected to decrease by -18.90% and hit $ 0.875911. As far as the long-term Atai Life Sciences N.V. stock forecast is ...

On average, Wall Street analysts predict. that Atai Life Sciences Nv's share price could reach $17.50 by Aug 14, 2024. The average Atai Life Sciences Nv stock price prediction forecasts a potential upside of 1,490.91% from the current ATAI share price of $1.10.

Nov 14, 2023 · Clinical-stage psychedelics company atai Life Sciences (NASDAQ: ATAI) reported its financial results and corporate updates for the third quarter ended September 30, 2023. In numbers: Consolidated Financial Results. Cash, Cash Equivalents, and Short-term investments: Cash, cash equivalents and short-term investments totaled $209.0 million as of September 30, 2023, compared to ...This influential firm issued a $20 share price target for ATAI, propelling its stock value to surge. As of May 24, 2023, ATAI Life Sciences boasts an average one-year price target of $13.75, as ...On December 2, 2023, the Board appointed Sahil Kirpekar, M.D. and Ryan Barrett as the new atai Board designees pursuant to the Rights Agreement, to serve until the 2024 annual meeting of the ...Atai Life Sciences N.V. (ATAI.NASDAQ) : Stock quote, stock chart, quotes, analysis, advice, financials and news for Stock Atai Life Sciences N.V. | Nasdaq: ...

Mar 27, 2023 · 0. These 7 analysts have an average price target of $13.29 versus the current price of ATAI Life Sciences at $1.3447, implying upside. Below is a summary of how these 7 analysts rated ATAI Life ... Atai Life Sciences’ (NASDAQ: ATAI) stock fell more than 40% after the primary endpoint of a phase 2a clinical trial examining the use of ketamine treatment to treat depression was not met.WebAre you tired of spending endless hours searching for high-quality stock photos only to discover that they come with a hefty price tag? Look no further. In this article, we will explore the best sources for high-quality really free stock ph...On December 2, 2023, the Board appointed Sahil Kirpekar, M.D. and Ryan Barrett as the new atai Board designees pursuant to the Rights Agreement, to serve until …The ATA Inc. stock price gained 7.69% on the last trading day (Friday, 1st Dec 2023), rising from $1.04 to $1.12. During the last trading day the stock fluctuated 12.20% from a day low at $1.03 to a day high of $1.15. The price has risen in 5 of the last 10 days and is up by 0.9% over the past 2 weeks. Volume fell on the last day by -2 million ...

Fundamentals ATAI LIFE SCIENCES BV EO1. Dividend. Dividend yield in %. P/E Ratio, -1.17. Profit per share, -0.84. Number of shares, 165.94 m. Market ...

2. Atai Life Sciences. Atai Life Sciences (ATAI 7.69%) is approaching psychedelic therapy development from the perspective of a venture capital investor. Each program in its pipeline is managed by ...Find the latest Earnings Report Date for ATAI Life Sciences N.V. Common Shares (ATAI) at Nasdaq.com.ATAI Signals & Forecast. There are mixed signals in the stock today. The ATA Inc. stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more …atai is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders and was founded as a response to the significant unmet need and lack of innovation ...ATAI Life Sciences N.V. Common Shares (ATAI) 0 Add to Watchlist Add to Portfolio Quotes Summary Real-Time After-Hours Live Key Data Bid Price and Ask Price The bid & ask refers to the price... May 25, 2023 · Over the past 12 months, ATAI’s stock has witnessed a remarkable growth rate of 631.38%. Despite its impressive performance in the stock market, ATAI has faced its fair share of challenges since ... Stock Price Forecast ... The 5 analysts offering 12-month price forecasts for ATAI Life Sciences NV have a median target of 11.00, with a high estimate of 21.00 ...Nov 17, 2023 · The upgrade of atai Life Sciences N.V. to a Zacks Rank #2 positions it in the top 20% of the Zacks-covered stocks in terms of estimate revisions, implying that the stock might move higher in the ... Discover historical prices for ATAI stock on Yahoo Finance. View daily, weekly or monthly format back to when Atai Life Sciences N.V. stock was issued.Atai Capital highlighted stocks like Alphabet Inc. (NASDAQ:GOOG) in the Q3 2023 investor letter. Headquartered in Mountain View, California, Alphabet Inc. (NASDAQ:GOOG) is a multinational ...

One example is the crashing of Atai Life Sciences (Nasdaq: ATAI) stock in January because of bad results from a Phase 2a proof-of-concept trial assessing the safety, tolerability, and efficacy of a single IV administration of ketamine. Shares of Atai’s stock crashed nearly 40% to an all-time low when the trial results were announced on Jan. 6.Web

atai Life Sciences has priced its upsized U.S. IPO of 15M common shares (from ~14.3M) at $15.00/share. Expected gross proceeds are $225M. Underwriters' over-allotment is an additional 2.25M shares.Web

On average, Wall Street analysts predict. that Atai Life Sciences Nv's share price could reach $17.50 by Aug 14, 2024. The average Atai Life Sciences Nv stock price prediction forecasts a potential upside of 1,490.91% from the current ATAI share price of $1.10. Atai Life Sciences (NASDAQ: ATAI) Psychedelic stocks have performed about as well as marijuana stocks over the last few months. Given the general uncertainties surrounding the future of recreational legislation, mass adoption from investors hasn’t necessarily been a trend. Nevertheless, that hasn’t stopped some from staking a claim in …The comedown has also put a dent in Angermayer’s wealth. Adjusting for its cash, investors now value Atai’s drug pipeline at $470 million. Nearly $1.8 billion was raised by psychedelics ...WebFind the latest Atari SA (PONGF) stock quote, history, news and other vital information to help you with your stock trading and investing. Atai Life Sciences Market Cap. Atai Life Sciences has a market cap or net worth of $180.95 million as of November 22, 2023. Its market cap has decreased by - ...Are you tired of spending endless hours searching for high-quality stock photos only to discover that they come with a hefty price tag? Look no further. In this article, we will explore the best sources for high-quality really free stock ph...The sector offers explosive growth potential, evidenced by the recent positive coverage of psychedelic stocks by investment research firms like Citi, Credit Suisse, Canaccord Genuity, and Cantor ...Find the latest Atari SA (PONGF) stock quote, history, news and other vital information to help you with your stock trading and investing.Oct 28, 2023 · 1. Atai Life Sciences. With prominent backing from venture capitalists, including billionaire Peter Thiel, it’s not surprising that Atai Life Sciences ranks as one of the biggest biotech stocks ... 35,390.15 +117.12(+0.33%) Nasdaq -15.00(-0.11%) Russell 2000 1,807.50 +11.96(+0.67%) Crude Oil 75.54 -1.56(-2.02%) Gold 2,003.00 +10.20(+0.51%) Atai Life Sciences N.V. (ATAI) NasdaqGM -...

Nov 29, 2021 · Meanwhile, Atai listed on the Nasdaq in June, raising $225 million at a valuation of $2.3 billion. The stock immediately popped 40% but it has since halved in value and Atai's current market cap ... Discover historical prices for ATAI stock on Yahoo Finance. View daily, weekly or monthly format back to when Atai Life Sciences N.V. stock was issued.29 thg 11, 2021 ... Atai Life Sciences, the Peter Thiel-backed psychedelic start-up, has increased its stake in Compass Pathways.Instagram:https://instagram. t shirt printing and fulfillment servicesgas vs electric car costqqqe stock pricecourses on presentation skills Nov 14, 2023 · Clinical-stage psychedelics company atai Life Sciences (NASDAQ: ATAI) reported its financial results and corporate updates for the third quarter ended September 30, 2023. In numbers: atai Life Sciences N.V. (ATAI) has been on a downward spiral lately with significant selling pressure. After declining 34.6% over the past four weeks, the stock looks well positioned for a trend ... books written by robert kiyosakiintra cellular According to 4 analysts, the average rating for ATAI stock is "Strong Buy." The 12-month stock price forecast is $13.5, which is an increase of 1,110.76% from the latest price. reit with high dividend Basic Membership Access to Journal, Shadow Stock portfolio & monthly updates for stock screens; A+ Investor Full access to AAII.com, Journal, and a power data suite for investment ideas; AAII Platinum Full access to all of AAII's model portfolios and premium services at a significant discountWebOpen Int (30-Day): The average total open interest for all option contracts (across all expiration dates) for the last 30 days. Atai Life Sciences N.V. stocks price quote with latest real-time prices, charts, financials, latest news, technical analysis and opinions.P/E & PEG Ratios. Investors may trade in the Pre-Market (4:00-9:30 a.m. ET) and the After Hours Market (4:00-8:00 p.m. ET). Participation from Market Makers and ECNs is strictly voluntary and as a ...